Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials.
Journal of the American College of Cardiology.
Times cited: 303
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: A meta-analysis.
Times cited: 105